Increase in epicardial fat volume is associated with greater coronary artery calcification progression in subjects at intermediate risk by coronary calcium score: a serial study using non-contrast cardiac CT.
暂无分享,去创建一个
D. Dey | D. Berman | H. Gransar | P. Slomka | R. Rajani | S. Hayes | R. Nakazato | V. Cheng | J. Friedman | Y. Otaki | L. Thomson | R. Nakanishi | H. Shmilovich
[1] K. Park,et al. Pericardial Fat Amount Is an Independent Risk Factor of Coronary Artery Stenosis Assessed by Multidetector‐Row Computed Tomography: The Korean Atherosclerosis Study 2 , 2011, Obesity.
[2] Damini Dey,et al. Interscan reproducibility of computer-aided epicardial and thoracic fat measurement from noncontrast cardiac CT. , 2011, Journal of cardiovascular computed tomography.
[3] Zahi A Fayad,et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2010, Circulation.
[4] Y. Yamashita,et al. Pericardial fat inflammation correlates with coronary artery disease. , 2010, Atherosclerosis.
[5] M. Budoff,et al. Increased epicardial, pericardial, and subcutaneous adipose tissue is associated with the presence and severity of coronary artery calcium. , 2010, Academic radiology.
[6] Piotr J. Slomka,et al. Increased pericardial fat volume measured from noncontrast CT predicts myocardial ischemia by SPECT. , 2010, JACC. Cardiovascular imaging.
[7] Damini Dey,et al. Pericardial fat burden on ECG-gated noncontrast CT in asymptomatic patients who subsequently experience adverse cardiovascular events. , 2010, JACC. Cardiovascular imaging.
[8] Daniel S Berman,et al. Determinants of coronary calcium conversion among patients with a normal coronary calcium scan: what is the "warranty period" for remaining normal? , 2010, Journal of the American College of Cardiology.
[9] I. Kakadiaris,et al. Computer-aided non-contrast CT-based quantification of pericardial and thoracic fat and their associations with coronary calcium and Metabolic Syndrome. , 2010, Atherosclerosis.
[10] A. Stillman,et al. Epicardial adipose tissue volume and coronary artery calcium to predict myocardial ischemia on positron emission tomography-computed tomography studies , 2010, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[11] Shyi-Jang Shin,et al. Increased epicardial adipose tissue (EAT) volume in type 2 diabetes mellitus and association with metabolic syndrome and severity of coronary atherosclerosis , 2009, Clinical endocrinology.
[12] Udo Hoffmann,et al. Association of pericardial fat, intrathoracic fat, and visceral abdominal fat with cardiovascular disease burden: the Framingham Heart Study. , 2008, European heart journal.
[13] Mathias Prokop,et al. Relation of epicardial and pericoronary fat to coronary atherosclerosis and coronary artery calcium in patients undergoing coronary angiography. , 2008, The American journal of cardiology.
[14] Á. L. Fernández,et al. Extension of coronary artery disease is associated with increased IL-6 and decreased adiponectin gene expression in epicardial adipose tissue. , 2008, Cytokine.
[15] Moyses Szklo,et al. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. , 2008, The New England journal of medicine.
[16] Udo Hoffmann,et al. Pericardial Fat, Visceral Abdominal Fat, Cardiovascular Disease Risk Factors, and Vascular Calcification in a Community-Based Sample: The Framingham Heart Study , 2008, Circulation.
[17] C. Hsieh,et al. Adipocytokines and proinflammatory mediators from abdominal and epicardial adipose tissue in patients with coronary artery disease , 2008, International Journal of Obesity.
[18] H. Sacks,et al. Human epicardial adipose tissue: a review. , 2007, American heart journal.
[19] S. Svacina,et al. Increased subcutaneous and epicardial adipose tissue production of proinflammatory cytokines in cardiac surgery patients: possible role in postoperative insulin resistance. , 2006, The Journal of clinical endocrinology and metabolism.
[20] R. Bonser,et al. Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease , 2006, Cardiovascular diabetology.
[21] D. Berman,et al. Concordance of coronary artery calcium estimates between MDCT and electron beam tomography. , 2005, AJR. American journal of roentgenology.
[22] R. Krauss,et al. Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement , 2005, Current opinion in cardiology.
[23] Fernando Costa,et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. , 2005, Circulation.
[24] F. Leonetti,et al. Adiponectin expression in human epicardial adipose tissue in vivo is lower in patients with coronary artery disease. , 2005, Cytokine.
[25] Carl D Langefeld,et al. Pericardial and Visceral Adipose Tissues Measured Volumetrically With Computed Tomography Are Highly Associated in Type 2 Diabetic Families , 2005, Investigative radiology.
[26] B. Goldstein,et al. Human Epicardial Adipose Tissue Is a Source of Inflammatory Mediators , 2003, Circulation.
[27] F. Leonetti,et al. Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: a new indicator of cardiovascular risk. , 2003, The Journal of clinical endocrinology and metabolism.
[28] D. Berman,et al. The metabolic syndrome, diabetes, and subclinical atherosclerosis assessed by coronary calcium. , 2003, Journal of the American College of Cardiology.
[29] S. Yamashita,et al. Abdominal fat: standardized technique for measurement at CT. , 1999, Radiology.
[30] R. Detrano,et al. Quantification of coronary artery calcium using ultrafast computed tomography. , 1990, Journal of the American College of Cardiology.
[31] N. Unwin,et al. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National , 2009 .
[32] J. Mckenney,et al. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). , 2001, JAMA.